AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Apr 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-04-17

Reporting Person: MCGLYNN MARGARET G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-17	Common Stock	M	10000	$2.81	Acquired	32064	Direct
2020-04-17	Common Stock	S	10000	$11.00	Disposed	22064	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-17	Stock Options (right to buy)	$2.81	M	10000	Disposed	2020-06-15	Common Stock (10000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: All of these options were fully vested and exercisable as of April 17, 2020.